Department of Antibody Engineering, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
Department of Biochemical and Cellular Pharmacology, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
Sci Rep. 2018 May 8;8(1):7136. doi: 10.1038/s41598-018-25609-z.
Outer membrane proteins (OMPs) in Gram-negative bacteria are essential for a number of cellular functions including nutrient transport and drug efflux. Escherichia coli BamA is an essential component of the OMP β-barrel assembly machinery and a potential novel antibacterial target that has been proposed to undergo large (~15 Å) conformational changes. Here, we explored methods to isolate anti-BamA monoclonal antibodies (mAbs) that might alter the function of this OMP and ultimately lead to bacterial growth inhibition. We first optimized traditional immunization approaches but failed to identify mAbs that altered cell growth after screening >3000 hybridomas. We then developed a "targeted boost-and-sort" strategy that combines bacterial cell immunizations, purified BamA protein boosts, and single hybridoma cell sorting using amphipol-reconstituted BamA antigen. This unique workflow improves the discovery efficiency of FACS + mAbs by >600-fold and enabled the identification of rare anti-BamA mAbs with bacterial growth inhibitory activity in the presence of a truncated lipopolysaccharide layer. These mAbs represent novel tools for dissecting the BamA-mediated mechanism of β-barrel folding and our workflow establishes a new template for the efficient discovery of novel mAbs against other highly dynamic membrane proteins.
革兰氏阴性菌的外膜蛋白 (OMPs) 对许多细胞功能至关重要,包括营养物质运输和药物外排。大肠杆菌 BamA 是 OMP β-桶组装机制的必需组成部分,也是一种潜在的新型抗菌靶标,据推测其会发生大 (~15 Å) 构象变化。在这里,我们探索了分离抗 BamA 单克隆抗体 (mAb) 的方法,这些 mAb 可能改变该 OMP 的功能,最终导致细菌生长抑制。我们首先优化了传统的免疫方法,但在筛选 >3000 个杂交瘤后,未能鉴定出改变细胞生长的 mAb。然后,我们开发了一种“靶向增强和分选”策略,该策略结合了细菌细胞免疫、纯化的 BamA 蛋白增强以及使用 Amphipol 重构的 BamA 抗原进行单个杂交瘤细胞分选。这种独特的工作流程将流式细胞术 + mAb 的发现效率提高了 >600 倍,并能够鉴定出在截短的脂多糖层存在下具有细菌生长抑制活性的罕见抗 BamA mAb。这些 mAb 代表了剖析 BamA 介导的 β-桶折叠机制的新型工具,我们的工作流程为高效发现针对其他高度动态膜蛋白的新型 mAb 建立了新模板。